Page 5 - Device Agency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid mcclungMiranda petoFinkelstein schoenfeldPeter altmanCompany annual report on formExchange commissionExchange commission onBiocardia incMaryland stem cell research fundDevice agencyBiocardia inc selected balance sheet dataMedicaid servicesBiocardia inc consolidated statements of operationsMorph access innovationsAutologous cell therapy

Biocardia Reports Fourth Quarter And Full Year 2023 Business Highlights And Financial Results

Biocardia Reports Fourth Quarter And Full Year 2023 Business Highlights And Financial Results
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanMiranda petoFinkelstein schoenfeldDavid mcclungDevice agencyExchange commission onMedicaid servicesExchange commissionBiocardia incMaryland stem cell research fundMorph access innovationsAutologous cell therapyTherapy heart failureHeart failure therapyMajor adverse coronary

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results

BioCardia Reports Fourth Quarter and Full Year 2023 Business Highlights and Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanMiranda petoFinkelstein schoenfeldDavid mcclungExchange commissionMedicaid servicesBiocardia incDevice agencyCompany annual report on formExchange commission onMaryland stem cell research fundCardia reports fourth quarterFull yearMorph access innovationsAutologous cell therapy

Krystal Biotech, Inc (NASDAQ:KRYS) Q4 2023 Earnings Call Transcript

Operator: Thank you for standing by and welcome to the Krystal Biotech Fourth Quarter and Full Year 2023 Earnings Conference Call. At this time, all participants are on a lesson-only mode.

United statesTim lugoGavin clark gartnerChristine wilsonAlec stranahanDebjit chattopadhyayJoe pantginisSuma krishnanKrish krishnanKate romanoWilliam blairKrystal biotech incEuropean medical agencyGoldman sachsCystic fibrosis foundationMost valuable tobacco companies

BioCardia Announces Expected CardiAMP Heart Failure Japan Approval Timeline Based on Pharmaceutical and Medical Device Agency Consultation Minutes

SUNNYVALE, Calif., Dec. 18, 2023 BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced.

United statesMiranda petoDavid mcclungPeter altmanDevice agencyMedicaid servicesCardiamp cell therapy programBiocardia incExchange commissionGlobenewswire incCenters for medicareMaryland stem cell research fundMedical device agencyFailure trialChief executiveCell therapy